Launch Tech Co Ltd Stock
Your prediction
Launch Tech Co Ltd Stock
There is an upward development for Launch Tech Co Ltd compared to yesterday, with an increase of €0.020 (2.680%).
Pros and Cons of Launch Tech Co Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Launch Tech Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Launch Tech Co Ltd | 2.680% | 0.000% | 1.987% | -42.537% | -18.259% | 234.783% | 78.241% |
| Chongqing Machinery & Electric Co Ltd | 1.020% | -2.000% | -10.909% | 40.000% | -6.667% | 237.931% | 340.449% |
| Jenoptik AG | 1.010% | -11.852% | -21.848% | 83.926% | 82.422% | 21.926% | 23.529% |
| Tennant Co. | 1.640% | 3.467% | -3.182% | 8.531% | 22.205% | - | - |
News
A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX shares have fallen below their $135 IPO price, erasing over $1 trillion in implied market value amid concerns about
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
Key Points
- Interested in Celcuity, Inc.? Here are five stocks we like better.
- Celcuity won full FDA approval for gedatolisib, now branded REVTORPYK, in a specific advanced breast cancer
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch
Key Points
- Interested in Vera Therapeutics, Inc.? Here are five stocks we like better.
- Vera Therapeutics won accelerated FDA approval for TRUTAKNA (atacicept-vymj) to treat adults with primary